Birmingham, West Midlands -- (SBWIRE) -- 01/22/2014 -- Value Penny Stocks issues special report on Generex Biotechnology Corporation (OTCMKTS:GNBT), American Realty Capital Properties Inc (NASDAQ:ARCP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), ThermoGenesis Corp (NASDAQ:KOOL).
Generex Biotechnology Corporation (OTCMKTS:GNBT) ended its recent business day with the gain of 4.65% and closed at the price of $0.0450 after opening at $0.04. The stock traded during its last trading session with the total volume of 16.45 million shares, as compared to its average volume of 5.63 million shares. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find Out Here
American Realty Capital Properties Inc (NASDAQ:ARCP) remained among the day advancers and traded with volume of 15.72 million shares in the last session, as compared to average volume of 5.81 million shares. In comparison with 52 week range of $12.13 - $18.05, it faced lowest price of $13.60 during the last trading session whereas its day highest price was $14.00. The company’s total market capitalization is $2.59 billion, along with 185.45 million shares outstanding. American Realty Capital Properties, Inc. owns and acquires single tenant, freestanding commercial real estate that is net leased on a medium-term basis, primarily to investment grade credit rated and other creditworthy tenants.
Why Should Investors Buy ARCP After The Recent Gain? Just Go Here and Find Out
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) showed 15.25 million shares in volume during the last trading session, while the average trading volume remained 29.46 million shares. The stock kicked off its trading session at $6.94 and closed at $6.60 after declining -4.35%. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Why Should Investors Buy ARIA After the Recent Fall? Just Go Here and Find Out
ThermoGenesis Corp (NASDAQ:KOOL) stock traded during its last trading session with the total traded volume of 15.13 million shares versus its average volume of 154,551.00 shares. The company opened its trade at the price of $1.38 and its closing price was $2.30 after gaining 111.01% for the day. ThermoGenesis Corp. designs, develops, and commercializes devices and disposable tools for the processing, storage, and administration of cell therapies. The company provides automated and semi-automated devices, and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells.
Why Should Investors Buy KOOL After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)